Development of a drug repressible β-catenin mutant mouse to examine effect of activated β-catenin signaling on long-term maintenance of mammary tumor growth
J. L. Gorman, J. R. Adams, E. M. Jones, S. E. Egan, J. R. Woodgett
This study develops a drug-repressible β-catenin mutant mouse model to investigate its role in long-term mammary tumor growth after initiation.
bioRxiv · Mar 26, 2019 · PreprintCancer Biology